Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness

IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

(2016) Song Gao et al.   CANCER RESEARCH

Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells

(2016) Ye Wang et al.   BioScience Trends

Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway

(2016) Guangzhi Wang et al.   Journal of Cancer

Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion

(2015) G. L. Razidlo et al.   CANCER RESEARCH

Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma

(2015) P.K. Singh et al.   IMMUNOBIOLOGY

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

(2015) D. Goldstein et al.   JNCI-Journal of the National Cancer Institute

Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis

(2015) J Jeffery et al.   ONCOGENE

Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma

(2015) Weijing Zhang et al.   TUMOR BIOLOGY

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

(2015) D. Goldstein et al.   JNCI-Journal of the National Cancer Institute

p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway

(2015) Nikhil Tyagi et al.   Oncotarget

Potent and Selective Small-Molecule Inhibitors of cIAP1/2 Proteins Reveal That the Binding of Smac Mimetics to XIAP BIR3 Is Not Required for Their Effective Induction of Cell Death in Tumor Cells

(2014) Haiying Sun et al.   ACS Chemical Biology

Pancreatic cancer genomics

(2014) David K Chang et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

CEP55 contributes to human gastric carcinoma by regulating cell proliferation

(2014) Jinqiu Tao et al.   TUMOR BIOLOGY

Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies

(2013) Marc Bardou et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Recent progress in pancreatic cancer

(2013) Christopher L. Wolfgang et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Centrosomal Protein 55 (Cep55) Stability Is Negatively Regulated by p53 Protein through Polo-like Kinase 1 (Plk1)

(2011) Yu-Chen Chang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

NF-κB promotes epithelial–mesenchymal transition, migration and invasion of pancreatic carcinoma cells

(2010) Harald J. Maier et al.   CANCER LETTERS

p53 negatively regulates expression of FoxM1

(2010) Bulbul Pandit et al.   CELL CYCLE

Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma

(2010) Ahmad Waseem et al.   ORAL ONCOLOGY

Oncoprotein Bmi-1 Renders Apoptotic Resistance to Glioma Cells through Activation of the IKK-Nuclear Factor-κB Pathway

(2009) Jun Li et al.   AMERICAN JOURNAL OF PATHOLOGY

Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity

(2009) C-H Chen et al.   ONCOGENE